BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 20706705)

  • 1. [Male breast cancer: a challenge for urologists].
    Hofer C; Schmalfeldt B; Gschwend JE; Herkommer K
    Urologe A; 2010 Sep; 49(9):1142, 1144-8. PubMed ID: 20706705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifocal male breast cancer: a case report.
    McQueen A; Cox J; Desai S; Moore R
    Clin Breast Cancer; 2007 Apr; 7(7):570-2. PubMed ID: 17509167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical research advancement on male breast cancer].
    Xue Y; Guo XT; Liu WC
    Ai Zheng; 2007 Oct; 26(10):1148-52. PubMed ID: 17927890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Male breast cancer].
    Mattson J; Vehmanen L
    Duodecim; 2016; 132(7):627-31. PubMed ID: 27188086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical and morphological features of breast cancer in men].
    Nikolaev KS
    Vopr Onkol; 2013; 59(3):358-62. PubMed ID: 23909038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Three men with breast cancer].
    Bergs EA; Tanis PJ; Steller EP
    Ned Tijdschr Geneeskd; 2005 Mar; 149(10):534-7. PubMed ID: 15782690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to treat male breast cancer.
    Czene K; Bergqvist J; Hall P; Bergh J
    Breast; 2007 Dec; 16 Suppl 2():S147-54. PubMed ID: 18210656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Male breast cancer.
    Ottini L; Palli D; Rizzo S; Federico M; Bazan V; Russo A
    Crit Rev Oncol Hematol; 2010 Feb; 73(2):141-55. PubMed ID: 19427229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Male breast cancer: prognostic factors, diagnosis and treatment: a multi-institutional survey of 95 cases].
    Oger AS; Boukerrou M; Cutuli B; Campion L; Rousseau E; Bussières E; Raro P; Classe JM
    Gynecol Obstet Fertil; 2015 Apr; 43(4):290-6. PubMed ID: 25818033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases.
    Cutuli B; Le-Nir CC; Serin D; Kirova Y; Gaci Z; Lemanski C; De Lafontan B; Zoubir M; Maingon P; Mignotte H; de Lara CT; Edeline J; Penault-Llorca F; Romestaing P; Delva C; Comet B; Belkacemi Y
    Crit Rev Oncol Hematol; 2010 Mar; 73(3):246-54. PubMed ID: 19442535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From adjuvant therapy to breast cancer prevention: BCPT and STAR.
    Dunn BK; Ford LG
    Breast J; 2001; 7(3):144-57. PubMed ID: 11469927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Male breast cancer.
    Gómez-Raposo C; Zambrana Tévar F; Sereno Moyano M; López Gómez M; Casado E
    Cancer Treat Rev; 2010 Oct; 36(6):451-7. PubMed ID: 20193984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Male breast cancer: a review].
    Comet B; Cutuli B; Penault-Llorca F; Bonneterre J; Belkacémi Y
    Bull Cancer; 2009 Feb; 96(2):181-9. PubMed ID: 19258225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An introduction to male breast cancer for urologists: epidemiology, diagnosis, principles of treatment, and special situations.
    Makdissi FBA; Santos SS; Bitencourt A; Campos FAB
    Int Braz J Urol; 2022; 48(5):760-770. PubMed ID: 35373955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies in treating male breast cancer.
    Cutuli B
    Expert Opin Pharmacother; 2007 Feb; 8(2):193-202. PubMed ID: 17257089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Male breast cancer: a disease distinct from female breast cancer.
    Gucalp A; Traina TA; Eisner JR; Parker JS; Selitsky SR; Park BH; Elias AD; Baskin-Bey ES; Cardoso F
    Breast Cancer Res Treat; 2019 Jan; 173(1):37-48. PubMed ID: 30267249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Recurrence or Contralateral Breast Cancer More than 5 Years After Diagnosis of Hormone Receptor-Positive Early-Stage Breast Cancer.
    Wilson S; Speers C; Tyldesley S; Chia S; Kennecke H; Ellard S; Lohrisch C
    Clin Breast Cancer; 2016 Aug; 16(4):284-90. PubMed ID: 26705158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients.
    Eggemann H; Ignatov A; Smith BJ; Altmann U; von Minckwitz G; Röhl FW; Jahn M; Costa SD
    Breast Cancer Res Treat; 2013 Jan; 137(2):465-70. PubMed ID: 23224235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.